Free equity investment tool of Japanese companies

Financial Indicator Details

Annual

First quarter

Second quarter

Third quarter

Sponsored Link

Related Company

POLA ORBIS HOLDINGS

タキロン

JSP

和光純薬工業

日本新薬

ZERIA PHARMACEUTICAL

KOSE

ZEON

日本曹達

MATSUMOTO YUSHI-SEIYAKU

DAISO

DAINICHISEIKA COLOR & CHEMICALS MFG.

TOYO INK SC HOLDINGS

KUREHA

参天製薬

EDIUNET Related Ranking

EDIUNET

EDIUNET Credit Rating

EDIUNET Industry Avg

EDIUNET Prefectures

Yuho! Industry

EDIUNET Rating News

Prev « 2024-04 » Next

Mon	Tue	Wed	Thu	Fri	Sat	Sun
1 -	2 -	3 -	4 -	5 -	6 -	7 -
8 -	9 -	10 -	11 -	12 -	13 -	14 -
15 -	16 -	17 -	18 -	19 -	20 -	21 -
22 -	23 -	24 -	25 -	26 -	27 -	28 -
29 -	30 -

[Update list]

1/28 Retail Trade (CAWACHI:A etc...

1/27 Banks (The Awa Bank:BBB→A)

1/23 Chemicals (Milbon:AA→AAA)

1/21 Glass & Ceramics Products (..

1/21 Machinery (TSUDAKOMA:C)

1/21 Other Services (Netindex.:CC)

1/20 Other Products (Kurogane Kos..

1/20 Wholesale Trade (リーバイ・..

1/20 Other Services (川崎地質:BB→..

1/17 Chemicals (Kawaguchi Chemica..

 RSS

 Company RSS

 Daily RSS

Sponsored Link

Recently Download Chart

Renesas Electronics

KIKUSUI ELECTRONICS etc.

KIKUSUI ELECTRONICS etc.

日本アビオニクス

日本アビオニクス

Financial Indicator Details: 和光純薬工業 (Annual )

Two or more periods are displayed by each of financial indicator collectively.Two or more companies can be compared and financial indicator data can also be downloaded.

【Analysis Menu】 Outline Statement Rating Indicator Download

Sponsored Link

*Free Download Financial Indicator data

Indicator Summary: 和光純薬工業 (Annual )

Consolidated :Indicator Consolidated | Non-Consolidated

Profitability	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Net profit margin (Industry Average)	6.32% (-12.05%)	5.73% (-0.50%)	7.20% (1.53%)	6.85% (-1.67%)	6.79% (3.05%)
C/F margin (Industry Average)	13.48% (-3.31%)	12.76% (8.51%)	17.65% (7.04%)	9.99% (6.35%)	12.16% (8.25%)
ROA (Industry Average)	3.46% (0.52%)	3.13% (1.04%)	3.89% (2.07%)	3.54% (0.06%)	3.39% (2.71%)
ROE (Industry Average)	4.40% (-1.43%)	4.03% (0.03%)	4.97% (2.96%)	4.46% (4.68%)	4.31% (4.57%)
Growth	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Equity growth (Industry Average)	- (-)	1.56% (5.01%)	2.35% (2.61%)	2.02% (-0.40%)	2.70% (8.16%)
Sales growth (Industry Average)	- (-)	2.73% (-2.67%)	0.42% (5.36%)	-3.75% (1.07%)	-0.07% (2.24%)
Net profit growth (Industry Average)	- (-)	-6.98% (203.46%)	26.20% (63.25%)	-8.35% (3.89%)	-0.94% (90.38%)
Operating C/F growth (Industry Average)	- (-)	-2.75% (275.10%)	38.93% (35.09%)	-45.50% (-6.09%)	21.57% (138.39%)
Stability	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Capital adequacy (Industry Average)	78.71% (53.80%)	77.79% (54.51%)	78.25% (55.00%)	79.40% (53.59%)	78.82% (56.30%)
Liquidity ratio (Industry Average)	513.55% (217.72%)	503.13% (225.70%)	519.33% (237.55%)	550.80% (239.89%)	523.02% (236.21%)
C/F ratio current liabilities (Industry Average)	192.37% (777.21%)	215.93% (303.31%)	158.05% (434.79%)	275.78% (929.73%)	245.91% (573.30%)
Quick ratio (Industry Average)	167.24% (138.97%)	176.32% (148.85%)	166.31% (156.17%)	164.98% (160.84%)	154.68% (156.81%)
Turnover	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Receivables turnover (Industry Average)	122.77day (83.89day)	140.62day (94.27day)	133.36day (93.96day)	138.71day (97.92day)	135.90day (98.27day)
Inventory turnover (Industry Average)	115.97day (54.45day)	98.66day (52.58day)	89.30day (52.64day)	98.93day (56.59day)	103.31day (58.68day)
Payable turnover (Industry Average)	55.16day (45.01day)	61.13day (49.82day)	57.13day (49.52day)	59.26day (52.10day)	57.11day (51.12day)
Working capita turnover (Industry Average)	183.58day (93.32day)	178.15day (97.02day)	165.53day (97.08day)	178.38day (102.41day)	182.11day (105.83day)
Stock etc.	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Market Value growth (Industry Average)	- (-)	- (34.57%)	- (1.49%)	- (-3.85%)	- (21.16%)
Dividend Yield (Industry Average)	- (3.20%)	- (1.93%)	- (2.17%)	- (2.45%)	- (2.07%)
PER (Industry Average)	- (25.22%)	- (23.06%)	- (16.22%)	- (29.19%)	- (16.58%)
PBR (Industry Average)	- (0.86%)	- (1.06%)	- (1.04%)	- (0.95%)	- (1.08%)
PCFR (Industry Average)	- (7.18%)	- (9.23%)	- (-2.43%)	- (9.50%)	- (7.56%)
PSR (Industry Average)	- (0.77%)	- (0.88%)	- (1.10%)	- (0.90%)	- (1.01%)

Non-Consolidated :Indicator Consolidated | Non-Consolidated

Profitability	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Net profit margin (Industry Average)	5.80% (-27.66%)	5.34% (-4.34%)	6.82% (-5.37%)	6.37% (-10.69%)	6.49% (8.92%)
C/F margin (Industry Average)	- (0.87%)	- (1.04%)	- (0.82%)	- (-0.81%)	- (-39.63%)
ROA (Industry Average)	3.22% (0.52%)	2.96% (0.92%)	3.74% (1.42%)	3.36% (-0.27%)	3.31% (1.53%)
ROE (Industry Average)	4.13% (-0.84%)	3.85% (-0.46%)	4.83% (1.81%)	4.27% (3.42%)	4.25% (2.62%)
Growth	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Equity growth (Industry Average)	- (-)	1.48% (3.64%)	2.42% (3.03%)	1.80% (0.04%)	1.88% (3.91%)
Sales growth (Industry Average)	- (-)	2.75% (-3.48%)	0.55% (6.70%)	-3.64% (0.75%)	-0.43% (-1.74%)
Net profit growth (Industry Average)	- (-)	-5.45% (166.48%)	28.57% (43.48%)	-9.98% (-47.04%)	1.37% (62.14%)
Operating C/F growth (Industry Average)	- (-)	- (89.80%)	- (77.44%)	- (-44.41%)	- (46.89%)
Stability	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Capital adequacy (Industry Average)	78.08% (56.79%)	76.95% (57.65%)	77.46% (57.17%)	78.64% (55.93%)	77.89% (57.57%)
Liquidity ratio (Industry Average)	488.02% (337.22%)	471.72% (276.75%)	485.19% (266.94%)	513.84% (314.47%)	481.47% (233.84%)
C/F ratio current liabilities (Industry Average)	- (48.90%)	- (53.10%)	- (31.35%)	- (76.77%)	- (31.87%)
Quick ratio (Industry Average)	160.82% (167.28%)	166.19% (183.78%)	153.95% (174.83%)	152.47% (228.06%)	138.87% (169.77%)
Turnover	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Receivables turnover (Industry Average)	128.32day (87.55day)	146.70day (98.39day)	138.33day (95.88day)	144.49day (98.58day)	141.73day (67.18day)
Inventory turnover (Industry Average)	111.40day (50.17day)	94.80day (48.43day)	86.33day (47.43day)	94.94day (50.67day)	98.43day (38.21day)
Payable turnover (Industry Average)	59.35day (45.70day)	65.83day (51.63day)	61.28day (51.13day)	63.33day (53.57day)	61.76day (34.24day)
Working capita turnover (Industry Average)	180.37day (92.02day)	175.68day (95.19day)	163.38day (92.19day)	176.11day (95.69day)	178.40day (71.15day)
Stock etc.	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Market Value growth (Industry Average)	- (-)	- (34.46%)	- (3.11%)	- (-3.30%)	- (24.19%)
Dividend Yield (Industry Average)	- (0.15%)	- (0.09%)	- (0.10%)	- (0.16%)	- (0.15%)
PER (Industry Average)	- (34.12%)	- (27.80%)	- (13.58%)	- (22.26%)	- (26.42%)
PBR (Industry Average)	- (0.97%)	- (1.21%)	- (1.17%)	- (1.08%)	- (1.54%)
PCFR (Industry Average)	- (0.27%)	- (0.62%)	- (0.23%)	- (0.08%)	- (4.97%)
PSR (Industry Average)	- (3.42%)	- (4.34%)	- (3.67%)	- (4.37%)	- (10.14%)

Financial Indicator Details: 和光純薬工業

Consolidated :Indicator Consolidated | Non-Consolidated

Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Profitability
Net profit margin	6.32%	5.73%	7.20%	6.85%	6.79%
C/F margin	13.48%	12.76%	17.65%	9.99%	12.16%
ROA	3.46%	3.13%	3.89%	3.54%	3.39%
ROE	4.40%	4.03%	4.97%	4.46%	4.31%
Recurring margin	10.14%	9.20%	11.80%	11.77%	10.73%
EBIT margin	9.82%	8.96%	11.59%	11.66%	10.65%
EBITDA margin	15.37%	13.85%	16.07%	16.04%	14.89%
NOPAT margin	5.89%	5.38%	6.95%	6.99%	6.39%
Sales SG rates	65.52%	67.19%	64.32%	62.88%	63.41%
Sales SG&A rates	24.66%	23.88%	23.89%	25.46%	26.00%
Sales R&D expenses rates	-	-	-	-	-
Sales depreciation rates	5.54%	4.88%	4.47%	4.38%	4.23%
Capital expenditures net sales ratio	-4.01%	-1.77%	-2.43%	-3.38%	-3.26%
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Growth
Growth rate of cash	-	6.12%	-1.46%	-27.07%	20.59%
Equity growth	-	1.56%	2.35%	2.02%	2.70%
Total assets growth	-	2.77%	1.75%	0.55%	3.45%
Sales growth	-	2.73%	0.42%	-3.75%	-0.07%
Net profit growth	-	-6.98%	26.20%	-8.35%	-0.94%
Operating C/F growth	-	-2.75%	38.93%	-45.50%	21.57%
Recurring profit growth	-	-6.77%	28.81%	-4.02%	-8.89%
EBIT growth	-	-6.27%	29.84%	-3.20%	-8.65%
EBITDA growth	-	-7.43%	16.50%	-3.92%	-7.21%
NOPAT growth	-	-6.27%	29.84%	-3.20%	-8.65%
Operating expenses growth	-	-	-	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Stability
Capital adequacy	78.71%	77.79%	78.25%	79.40%	78.82%
Liquidity ratio	513.55%	503.13%	519.33%	550.80%	523.02%
C/F ratio current liabilities	192.37%	215.93%	158.05%	275.78%	245.91%
Quick ratio	167.24%	176.32%	166.31%	164.98%	154.68%
Fixed ratio	26.39%	24.42%	22.73%	22.47%	23.43%
D/E ratio	0.33%	0.17%	-	-	-
Loan to Value Ratio	0.25%	0.13%	-	-	-
Business investment C/F ratio	-29.74%	-13.91%	-13.79%	-33.82%	-26.88%
Liabilities with interest growth	-	-47.45%	-100.00%	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Turnover
Cash turnover	35.55day	36.73day	36.03day	27.30day	32.95day
Receivables turnover	122.77day	140.62day	133.36day	138.71day	135.90day
Inventory turnover	115.97day	98.66day	89.30day	98.93day	103.31day
Fixed assets turnover	138.36day	126.61day	120.11day	125.86day	134.88day
Total asset turnover	666.01day	666.22day	675.05day	705.27day	730.21day
Payable turnover	55.16day	61.13day	57.13day	59.26day	57.11day
Capital turnover	11.44day	11.14day	11.09day	11.52day	11.53day
Equity turnover	524.27day	518.30day	528.25day	559.99day	575.57day
Working capita turnover	183.58day	178.15day	165.53day	178.38day	182.11day
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Balance sheet
Cash etc.	¥ 7 B	¥ 7 B	¥ 7 B	¥ 5 B	¥ 6 B
Accounts receivable-trade	¥ 25 B	¥ 29 B	¥ 28 B	¥ 28 B	¥ 27 B
Other Current Assets	¥ 92 B	¥ 98 B	¥ 103 B	¥ 106 B	¥ 109 B
Current Assets	¥ 99 B	¥ 106 B	¥ 111 B	¥ 112 B	¥ 115 B
Tangible Assets	¥ 28 B	¥ 26 B	¥ 25 B	¥ 25 B	¥ 27 B
Intangible Assets	¥ 917 M	¥ 804 M	¥ 754 M	¥ 732 M	¥ 690 M
Investment etc.	¥ 7 B	¥ 6 B	¥ 4 B	¥ 4 B	¥ 4 B
Total Assets	¥ 136 B	¥ 139 B	¥ 142 B	¥ 143 B	¥ 148 B
Current Liabilities	¥ 19 B	¥ 21 B	¥ 21 B	¥ 20 B	¥ 22 B
Fixed Liabilities	¥ 9 B	¥ 9 B	¥ 9 B	¥ 9 B	¥ 9 B
Liabilities with interest	¥ 354 M	¥ 186 M	-	-	-
Net Assets	¥ 107 B	¥ 108 B	¥ 111 B	¥ 113 B	¥ 116 B
Capital stock	¥ 2 B	¥ 2 B	¥ 2 B	¥ 2 B	¥ 2 B
Capital surplus etc.	¥ 104 B	¥ 106 B	¥ 109 B	¥ 111 B	¥ 114 B
Liabilities and net assets	¥ 136 B	¥ 139 B	¥ 142 B	¥ 143 B	¥ 148 B
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Income statement
Sales	¥ 74 B	¥ 76 B	¥ 76 B	¥ 74 B	¥ 74 B
Cost of Sales	¥ 48 B	¥ 51 B	¥ 49 B	¥ 46 B	¥ 46 B
Gross profit	¥ 25 B	¥ 25 B	¥ 27 B	¥ 27 B	¥ 27 B
Other income	¥ 635 M	¥ 348 M	¥ 271 M	¥ 253 M	¥ 366 M
SG&A	¥ 18 B	¥ 18 B	¥ 18 B	¥ 18 B	¥ 19 B
Other expenses	¥ 3 B	¥ 2 B	¥ 3 B	¥ 3 B	¥ 3 B
Net income	¥ 4 B	¥ 4 B	¥ 5 B	¥ 5 B	¥ 5 B
Operating income	¥ 7 B	¥ 6 B	¥ 9 B	¥ 8 B	¥ 7 B
Ordinary Income	¥ 7 B	¥ 7 B	¥ 9 B	¥ 8 B	¥ 7 B
EBITDA	¥ 11 B	¥ 10 B	¥ 12 B	¥ 11 B	¥ 11 B
Income before income taxes	¥ 7 B	¥ 6 B	¥ 8 B	¥ 8 B	¥ 7 B
Depreciation	¥ 4 B	¥ 3 B	¥ 3 B	¥ 3 B	¥ 3 B
R&D expenses	-	-	-	-	-
Income taxes	¥ 2 B	¥ 2 B	¥ 3 B	¥ 3 B	¥ 2 B
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Cash flow statement
Operating CF	¥ 10 B	¥ 9 B	¥ 13 B	¥ 7 B	¥ 9 B
Investment CF	¥ -3 B	¥ -274 M	¥ -839 M	¥ -2 B	¥ -3 B
Financial CF	¥ -4 B	¥ -4 B	¥ -4 B	¥ -4 B	¥ -4 B
Foreign Exchange Effects	¥ -363 M	¥ -84 M	¥ -134 M	¥ -128 M	¥ 302 M
Net Change in Cash	¥ 1 B	¥ 4 B	¥ 8 B	¥ 302 M	¥ 1 B
Free CF	¥ 6 B	¥ 9 B	¥ 12 B	¥ 4 B	¥ 5 B
Capital expenditures	¥ -2 B	¥ -1 B	¥ -1 B	¥ -2 B	¥ -2 B
Cash dividends paid	¥ -2 B	¥ -2 B	¥ -2 B	¥ -2 B	¥ -2 B
Repayment loans	-	-	-	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Shareowners' equity
Issuance of new shares	-	-	-	-	-
Dividends from surplus	¥ -2 B	¥ -2 B	¥ -2 B	¥ -2 B	¥ -2 B
Net income	¥ 4 B	¥ 4 B	¥ 5 B	¥ 5 B	¥ 5 B
Purchase of treasury stock	¥ -2 M	¥ -2 M	-	¥ -3 M	¥ -2 M
Other Change in Stockholders Equity	-	-	-	-	-
Other Change in Net Assets	¥ -648 M	¥ -160 M	¥ -397 M	¥ -169 M	¥ 729 M
Net Change in Net Assets	¥ 1 B	¥ 1 B	¥ 2 B	¥ 2 B	¥ 3 B

Financial Indicator Details: 和光純薬工業

Non-Consolidated :Indicator Consolidated | Non-Consolidated

Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Profitability
Net profit margin	5.80%	5.34%	6.82%	6.37%	6.49%
C/F margin	-	-	-	-	-
ROA	3.22%	2.96%	3.74%	3.36%	3.31%
ROE	4.13%	3.85%	4.83%	4.27%	4.25%
Recurring margin	9.32%	8.52%	11.12%	10.94%	10.02%
EBIT margin	9.38%	8.50%	11.05%	10.94%	10.03%
EBITDA margin	9.38%	8.50%	11.05%	10.94%	10.03%
NOPAT margin	5.63%	5.10%	6.63%	6.56%	6.02%
Sales SG rates	67.48%	68.70%	65.78%	64.52%	65.17%
Sales SG&A rates	23.79%	23.18%	23.26%	24.71%	25.10%
Sales R&D expenses rates	-	-	-	-	-
Sales depreciation rates	-	-	-	-	-
Capital expenditures net sales ratio	-	-	-	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Growth
Growth rate of cash	-	1.16%	-8.25%	-44.65%	13.13%
Equity growth	-	1.48%	2.42%	1.80%	1.88%
Total assets growth	-	2.96%	1.75%	0.27%	2.86%
Sales growth	-	2.75%	0.55%	-3.64%	-0.43%
Net profit growth	-	-5.45%	28.57%	-9.98%	1.37%
Operating C/F growth	-	-	-	-	-
Recurring profit growth	-	-6.06%	31.26%	-5.20%	-8.79%
EBIT growth	-	-6.87%	30.65%	-4.59%	-8.66%
EBITDA growth	-	-6.87%	30.65%	-4.59%	-8.66%
NOPAT growth	-	-6.87%	30.65%	-4.59%	-8.66%
Operating expenses growth	-	-	-	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Stability
Capital adequacy	78.08%	76.95%	77.46%	78.64%	77.89%
Liquidity ratio	488.02%	471.72%	485.19%	513.84%	481.47%
C/F ratio current liabilities	-	-	-	-	-
Quick ratio	160.82%	166.19%	153.95%	152.47%	138.87%
Fixed ratio	24.59%	22.82%	21.47%	21.31%	22.43%
D/E ratio	-	-	-	-	-
Loan to Value Ratio	-	-	-	-	-
Business investment C/F ratio	-	-	-	-	-
Liabilities with interest growth	-	-	-	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Turnover
Cash turnover	26.37day	25.97day	23.69day	13.60day	15.46day
Receivables turnover	128.32day	146.70day	138.33day	144.49day	141.73day
Inventory turnover	111.40day	94.80day	86.33day	94.94day	98.43day
Fixed assets turnover	126.01day	115.51day	110.71day	116.06day	125.01day
Total asset turnover	656.25day	657.60day	665.43day	692.48day	715.41day
Payable turnover	59.35day	65.83day	61.28day	63.33day	61.76day
Capital turnover	11.80day	11.48day	11.41day	11.85day	11.90day
Equity turnover	512.43day	506.06day	515.48day	544.62day	557.28day
Working capita turnover	180.37day	175.68day	163.38day	176.11day	178.40day
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Balance sheet
Cash etc.	¥ 5 B	¥ 5 B	¥ 4 B	¥ 2 B	¥ 3 B
Accounts receivable-trade	¥ 25 B	¥ 29 B	¥ 28 B	¥ 28 B	¥ 27 B
Other Current Assets	¥ 87 B	¥ 94 B	¥ 99 B	¥ 102 B	¥ 104 B
Current Assets	¥ 93 B	¥ 99 B	¥ 104 B	¥ 105 B	¥ 107 B
Tangible Assets	¥ 24 B	¥ 23 B	¥ 22 B	¥ 22 B	¥ 24 B
Intangible Assets	¥ 750 M	¥ 664 M	¥ 653 M	¥ 656 M	¥ 618 M
Investment etc.	¥ 11 B	¥ 9 B	¥ 8 B	¥ 7 B	¥ 8 B
Total Assets	¥ 130 B	¥ 134 B	¥ 136 B	¥ 136 B	¥ 140 B
Current Liabilities	¥ 19 B	¥ 21 B	¥ 21 B	¥ 20 B	¥ 22 B
Fixed Liabilities	¥ 9 B	¥ 9 B	¥ 9 B	¥ 8 B	¥ 8 B
Liabilities with interest	-	-	-	-	-
Net Assets	¥ 101 B	¥ 103 B	¥ 105 B	¥ 107 B	¥ 109 B
Capital stock	¥ 2 B	¥ 2 B	¥ 2 B	¥ 2 B	¥ 2 B
Capital surplus etc.	¥ 99 B	¥ 100 B	¥ 103 B	¥ 105 B	¥ 107 B
Liabilities and net assets	¥ 130 B	¥ 134 B	¥ 136 B	¥ 136 B	¥ 140 B
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Income statement
Sales	¥ 72 B	¥ 74 B	¥ 74 B	¥ 72 B	¥ 71 B
Cost of Sales	¥ 48 B	¥ 51 B	¥ 49 B	¥ 46 B	¥ 46 B
Gross profit	¥ 23 B	¥ 23 B	¥ 25 B	¥ 25 B	¥ 24 B
Other income	¥ 680 M	¥ 416 M	¥ 339 M	¥ 277 M	¥ 404 M
SG&A	¥ 17 B	¥ 17 B	¥ 17 B	¥ 17 B	¥ 18 B
Other expenses	¥ 2 B	¥ 2 B	¥ 3 B	¥ 3 B	¥ 2 B
Net income	¥ 4 B	¥ 3 B	¥ 5 B	¥ 4 B	¥ 4 B
Operating income	¥ 6 B	¥ 6 B	¥ 8 B	¥ 7 B	¥ 6 B
Ordinary Income	¥ 6 B	¥ 6 B	¥ 8 B	¥ 7 B	¥ 7 B
EBITDA	¥ 6 B	¥ 6 B	¥ 8 B	¥ 7 B	¥ 7 B
Income before income taxes	¥ 6 B	¥ 6 B	¥ 8 B	¥ 7 B	¥ 7 B
Depreciation	-	-	-	-	-
R&D expenses	-	-	-	-	-
Income taxes	¥ 2 B	¥ 2 B	¥ 3 B	¥ 3 B	¥ 2 B
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Cash flow statement
Operating CF	-	-	-	-	-
Investment CF	-	-	-	-	-
Financial CF	-	-	-	-	-
Foreign Exchange Effects	-	-	-	-	-
Net Change in Cash	-	-	-	-	-
Free CF	-	-	-	-	-
Capital expenditures	-	-	-	-	-
Cash dividends paid	-	-	-	-	-
Repayment loans	-	-	-	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Shareowners' equity
Issuance of new shares	-	-	-	-	-
Dividends from surplus	¥ -2 B	¥ -2 B	¥ -2 B	¥ -2 B	¥ -2 B
Net income	¥ 4 B	¥ 3 B	¥ 5 B	¥ 4 B	¥ 4 B
Purchase of treasury stock	¥ -2 M	¥ -2 M	-	¥ -3 M	¥ -2 M
Other Change in Stockholders Equity	-	-	-	-	-
Other Change in Net Assets	¥ -163 M	¥ 83 M	¥ -19 M	¥ -42 M	¥ 50 M
Net Change in Net Assets	¥ 1 B	¥ 1 B	¥ 2 B	¥ 1 B	¥ 2 B

Free Download

*Free Download Financial Indicator dataMember limited service.

[Data] Net Profit Margin, Sales Growth, Equity Margin etc., 100 or more kinds of financial indicators. (*Consolidated or Non-Consolidated. two or more terms)

Sponsored Link

Related Information: 和光純薬工業 (Annual )

Statement Type

Annual : 和光純薬工業

Second quarter : 和光純薬工業

Analysis Menu

Outline : 和光純薬工業

Statement : 和光純薬工業

Rating : 和光純薬工業

Indicator : 和光純薬工業

Download : 和光純薬工業

Industry Comparison Ranking

Chemicals - EDIUNET Industry Rankings

Chemicals - EDIUNET Credit Rating

Chemicals - EDIUNET Industry Avg

Comparison with a neighboring company

Osaka - EDIUNET Prefectures

Osaka大阪市 - EDIUNET Prefectures

Related company's newest statement

Date	Company	Credit Rating	Date
1/23	Milbon	AA→AAA	2013-12-20
1/17	Kawaguchi Chemical Indu..	BBB→BB	2013-11-30
1/17	SANKEI CHEMICAL	A	2013-11-30
1/15	HOKKO CHEMICAL INDUSTRY	BB→B	2013-11-30
1/15	Daito Pharmaceutical Co .	AA	2013-11-30 (Q2)
1/15	KAWAKAMI PAINT MFG.	B→BB	2013-11-30
1/15	旭化学工業	AA	2013-11-30 (Q1)
1/10	OSAKA ORGANIC CHEMICAL ..	BB→BBB	2013-11-30
1/10	HISAMITSU PHARMACEUTICAL	A	2013-11-30 (Q3)
1/10	AMS Life Science	BBB→BB	2013-11-30 (Q1)

EDIUNET Investment News (Chemicals)

1/23 Chemicals (Milbon:AA→AAA)

1/17 Chemicals (Kawaguchi Chemica..

1/15 Chemicals (HOKKO CHEMICAL IN..

1/10 Chemicals (OSAKA ORGANIC CHE..

1/9 Chemicals (SANKO GOSEI:A)

12/27 Chemicals (Niitaka:A)

12/18 Chemicals (KUMIAI CHEMICAL I..

12/12 Chemicals (IHARA CHEMICAL IN..

12/11 Chemicals (Konoshima Chemica..

12/10 Chemicals (NATOCO:AA)

Company Information

Ticker	Market	Industry	Month	report	Rating
和光純薬工業			Chemicals	3	Annual	BBB

Related Company

Sumitomo Seika Chemicals (Sales ¥ 70 B)

Central Glass (Sales ¥ 173 B)

DAISO (Sales ¥ 83 B)

ZERIA PHARMACEUTICAL (Sales ¥ 53 B)

Milbon (Sales ¥ 23 B)

参天製薬 (Sales ¥ 119 B)

kyowa Hakko Kirin (Sales ¥ 333 B)

KUREHA (Sales ¥ 130 B)

Eisai (Sales ¥ 573 B)

タキロン (Sales ¥ 67 B)

日本新薬 (Sales ¥ 69 B)

AIR WATER (Sales ¥ 540 B)

KAKEN PHARMACEUTICAL (Sales ¥ 87 B)

関連する株式投資情報

EDIUNET Caution

*Financial data might be different from the actual one. Please confirm the original, and read Caution.

*This site has obtained the information from the FSA's EDINET, Tokyo Stock Exchange's TDnet and Pay statistical data services, Fukuoka stock Exchange's Stock market capitalization, Center for Spatial Information Science's CSV Geocoding Service. The copyright of the information belongs to each corporation etc. .